Synthesis and antitumor activity of cis-dichloridoplatinum(II) complexes of 1,1′-biisoquinolines

European Journal of Medicinal Chemistry

Volumn 45, Issue 1, 2010, Pages 55-62

  Kuo, Chen Yuan ^a   Wu, Ming Jung ^b   Lin, Chu Chieh ^c  

^a YUNG TA INSTITUTE OF TECHNOLOGY AND COMMERCE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Antitumor activity; Biisoquinoline; Bischler Napieralski

Indexed keywords

(6,6',7,7' TETRAMETHOXY 1,1',2,2',3,3',4,4' OCTAHYDRO 1,1' BIISOQUINOLINE)DICHLORIDOPLATINUM; (6,6',7,7' TETRAMETHOXY 3,3',4,4' TETRAHYDRO 1,1' BIISOQUINOLINE)DICHLORIDOPLATINUM; (MESO 6,6',7,7' TETRAMETHOXY 1,1',2,2',3,3',4,4' OCTAHYDRO 1,1' BIISOQUINOLINE)DICHLORIDOPLATINUM; (RAC 6,6',7,7' TETRAMETHOXY 1,1',2,2',3,3',4,4' OCTAHYDRO 1,1' BIISOQUINOLINE)DICHLORIDOPLATINUM; AMIDE; ANTINEOPLASTIC AGENT; CHLORIDE; CISPLATIN; ISOQUINOLINE DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; CYCLIZATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; IMINES; INHIBITORY CONCENTRATION 50; ISOQUINOLINES; ORGANOPLATINUM COMPOUNDS;

EID: 72049085269     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.09.023     Document Type: Article

References (25)

1. Shin E.J., Hajaligol M.R., and Rasouli F. Fuel 83 (2004) 1445-1453
2. Carroll A.R., Davis R.A., Forster P.I., Guymer G.P., and Quinn R.J. J. Nat. Prod. 64 (2001) 1572-1573
3. Rashid M.A., Gustafson K.R., and Boyd M.R. J. Nat. Prod. 64 (2001) 1249-1250
4. Sotomayeor N., Dominguez E., and Lete E. J. Org. Chem. 61 (1996) 4062-4072
5. Kim S.A., Kwon Y., Kim J.H., Muller M.T., and Chung I.K. Biochemistry 37 (1998) 16316-16324
6. Orito K., Miyazawa M., Kanbayashi R., Tokuda M., and Suginome H. J. Org. Chem. 64 (1999) 6583-6596
7. Charifson P.S., Bowen J.P., Wyrick S.D., Hoffman A.J., Cory M., McPhail A.T., and Mailman R.B. J. Med. Chem. 32 (1989) 2050-2058
8. Beaumont D., Waigh R.D., Sunbhanich M., and Nott M.W. J. Med. Chem. 29 (1983) 507-515
9. Nielsen A.H. J. Org. Chem. 35 (1970) 2498-2503
10. Kato M., Sasano K., Kosuge C., Yamazaki M., Yano S., and Kimura M. Inorg. Chem. 35 (1996) 116-123
11. Plaquevent J.C., Perrard T., and Cahard C. Chemistry 8 (2002) 3300-3307
12. Lucet D., Toupet L., Le G.T., and Mioskowski C. J. Org. Chem. 62 (1997) 2682-2683
13. Jamieson E.R., and Lippard S.L. Chem. Rev. 99 (1999) 2467-2498
14. Ott H., Hardtmann G.E., Albert M.D., Frey A.J., Gogerty J.H., Leslie G.H., and Trapold J.H. Journal of Medicinal Chemistry (1968) 777-787
15. Gensler W.J. In: Adams R. (Ed). Organic Reactions vol. 6 (1951), Wiley, New York 191-206
16. Judeh Z.M.A., Ching C.B., Bu J., and McCluskey A. Tetrahedron. Lett. 29 (2002) 5089-5091
17. Ano S.O., Intini F.P., Natile G., and Marzilli L.G. Inorg. Chem. 38 (1999) 2989-2999
18. Abrams M.J., and Murrer B.A. Science 261 (1993) 725-731
19. Fuertes M.A., Alonso C., and Perez J.M. Chem. Rev. 103 (2003) 645-662
20. Kuo C.Y., Wu M.J., and Kuo Y.H. Eur. J. Med. Chem. 41 (2006) 940-949
21. Cram D.J., and Elhafez F.A.A. J. Am. Chem. Soc. 74 (1952) 5828-5835
22. Elliott M.C., and Williams E. Org. Biomol. Chem. 1 (2003) 3038-3047
23. D'Ocon P., Blasco R., Candenas L., Ivorra D., Lopez S., Villaverde C., Castedo L., and Cortes D. Eur. J. Pharmacol. 196 (1991) 183-187
24. Sun C.M., Syu W.J., Huang Y.T., Chen C.C., and Ou J.C. J. Nat. Prod. 60 (1997) 382-384
25. Mosmann T.J. J. Immunol. Meth. 65 (1983) 55-63